5636 results about "Greek letter alpha" patented technology

A method for forming a metal interconnect on a substrate is provided. The method includes depositing a refractory metal-containing barrier layer having a thickness less than about 20 angstroms on at least a portion of a metal layer by alternately introducing one or more pulses of a metal-containing compound and one or more pulses of a nitrogen-containing compound. The method also includes depositing a seed layer on at least a portion of the barrier layer, and depositing a second metal layer on at least a portion of the seed layer. The barrier layer provides adequate barrier properties and allows the grain growth of the metal layer to continue across the barrier layer into the second metal layer thereby enhancing the electrical performance of the interconnect.

Methods and compositions for the treatment of conditions including ocular, stress-associated, and neurodegenerative conditions in a mammal using a composition which directly or indirectly stimulates alpha 2 adrenoreceptor agonist activity with a minimum of sedation or other side effects.

Graphical objects, such as documents and pop-up items, are projected onto a display surface of a touch-sensitive graphical user interface. The pop-up items associated with a particular document are displayed at a distance from the document. The distance is sufficient to prevent occlusion of the associated document when any of the pop-up items are touched. The pop-up items are connected visually with the particular document by transparent, that is, alpha-blended, colored triangles, so that the pop-up items appear to hover above the display surface.

Methods and compositions for the prevention and treatment of all forms of atherosclerosis are described. Administration of compounds such as thalidomide, its analogs, hydrolysis products, metabolites, derivatives and precursors as well as additional compounds capable of inhibiting tumor necrosis factor alpha (TNF-alpha) are used in the invention. Also disclosed is the coating of prosthetic devices, such as stents, with the compounds of the invention for the prevention and/or treatment of restenosis.

Ophthalmic formulations are provided. The ophthalmic formulations include one or more active agents that act to optimize pupil light reflex while minimizing, or effectively eliminating, any undesired eye redness in response to application thereof. The active agents include, for example, alpha 1 antagonists, such as alpha la selective antagonists.

Foamable compositions and foams comprise at least an ethylene/α-olefin interpolymer. The foam has a density from greater than 150 to about 500 kg/m³. The foamable compositions further comprise a blowing agent and a crosslinking agent. The ethylene/α-olefin interpolymers are a multi-block copolymer comprising at least one soft block and at least one hard block. Methods of making the foamable compositions and foams; and foamed articles made from the foams are also described.

Objects of interest are detected and identified using multiple cameras having varying resolution and imaging parameters. An object is first located using a low resolution camera. A second camera (or lens) is then directed at the object's location using a steerable mirror assembly to capture a high-resolution image at a location where the object is thought to be based on image acquired by the wide-angle camera. Various image processing algorithms may be applied to confirm the presence of the object in the telephoto image. If an object is detected and the image is of sufficiently high quality, detailed facial, alpha-numeric, or other pattern recognition techniques may be applied to the image.

The present invention relates to at least one novel anti-alpha-V subunit antibodies, including isolated nucleic acids that encode at least one anti-alpha-V subunit antibody, alpha-V subunit, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.

The instant invention provides a method for improving the miscibility of the lower molecular weight unsaturated siloxane-polyether copolymers with the alpha , omega -divinylpolysiloxanes without loss of storage stability, or delay of cure at the vulcanization temperature, or loss of permanent hydrophilicity or other desirable features of the cured polysiloxane. The compositions of the present invention comprise one or more alpha , omega -divinylpolysiloxanes, unsaturated polysiloxane-polyether copolymers having from 2 to 5 silicon atoms per molecule which are preferably trisiloxanes, and a compatibilizing additive. The permanently hydrophilic, rapidly wettable polysiloxane compositions yield static water contact angles <50 DEG dynamic advancing contact angles of less than about 100.

The present invention provides CMP abrasive slurry that is substantially free of aluminum oxide and comprises liquid and solids wherein the solids comprises: (a) in an amount of at least about 90 weight percent based on the solids, at least one non-spherical component having formula Al₂O₃.xH₂O where x ranges from 1 to 3; and (b) up to about one weight percent based on the solids portion of submicron alpha-alumina. The CMP abrasive slurry may be used to polish metallic or dielectric surfaces in computer wafers.

This invention relates to a process to produce a polyalpha-olefin comprising: 1) contacting one or more alpha-olefin monomers having 3 to 24 carbon atoms with an unbridged substituted bis cyclopentadienyl transition metal compound having: 1) at least one non-isoolefin substitution on both cyclopentadientyl rings, or 2) at least two substitutions on at least one cyclopentadienyl ring, a non-coordinating anion activator, and optionally an alkyl-aluminum compound, where the molar ratio of transition metal compound to activator is 10:1 to 0.1:1, and if the alkyl aluminum compound is present then the molar ratio of alkyl aluminum compound to transition metal compound is 1:4 to 4000:1, under polymerization conditions wherein: i) hydrogen is present at a partial pressure of 0.1 to 50 psi, based upon the total pressure of the reactor or the concentration of the hydrogen is from 1 to 10,000 ppm or less by weight; ii) wherein the alpha-olefin monomer(s) having 3 to 24 carbon atoms are present at 10 volume % or more based upon the total volume of the catalyst/activator/alkylaluminum compound solutions, monomers, and any diluents or solvents present in the reaction; iii) the residence time of the reaction is at least 5 minutes; iv) the productivity of the process is at least 43,000 grams of total product per gram of transition metal compound; v) the process is continuous or semi-continuous, and vi) the temperature in the reaction zone does not rise by more than 10° C. during the reaction; and vii) ethylene is not present at more than 30 volume % of the monomers entering the reaction zone; and 2) obtaining a polyalpha-olefin (PAO), optionally hydrogenating the PAO, wherein the PAO comprises at least 50 mole % of a C3 to C24 alpha-olefin monomer, and wherein the PAO has a kinematic viscosity at 100° C. of 20 cSt or less.

Disclosed herein is a polymer comprising an amorphous syndiotactic rich polyolefin comprising greater than about 50 wt % C₃-C₄₀ alpha olefins and having about 50% to less than about 80% r dyads, based on the total number of r and m dyads present in the polymer; a heat of fusion of 10 joules/g or less according to the procedure described in ASTM E 794-85; and an ash content of 1 wt % or less. A functionalized amorphous syndiotactic rich polyolefin is also disclosed, along with methods to produce and a method to use the inventive polymer.

Retrieving a desired telephone number from a database in a mobile communication unit is facilitated by utilizing the frequency with which the user calls each telephone number stored in the database in a manner that allows the mobile communication unit to make a “best guess” of which phone number the user is seeking each time the user pushes a key while inputting a name or character string representing the person that the user wishes to call from the mobile communication unit. If the database does not include any name or character string potentially matching a desired character string entered via a keypad, the mobile communication unit automatically switches to normal phone number entry mode.

Anti-blocking polymer compositions comprise at least one ethylene/α-olefin interpolymer and at least one anti-blocking agent comprising an amide. The ethylene/α-olefin interpolymers are a multi-block copolymer comprising at least one soft block and at least one hard block. The anti-blocking agent can be erucamide or other amides. The anti-blocking polymer composition has a pellet blocking strength of equal to or less than 100 lbs/ft² (4800 Pa). When the anti-blocking polymer composition is made into a film, the film has a blocking force of less than about 100 grams, measured according to ASTM method D-3354.

This invention relates to a method for the biochemical treatment of persistent pain disorders by inhibiting the biochemical mediators of inflammation in a subject comprising administering to said subject any one of several combinations of components that are inhibitors of biochemical mediators of inflammation. Said process for biochemical treatment of persistent pain disorders is based on Sota Omoigui's Law, which states: ‘The origin of all pain is inflammation and the inflammatory response’. Sota Omoigui's Law of Pain unifies all pain syndromes as sharing a common origin of inflammation and the inflammatory response. The various biochemical mediators of inflammation are present in differing amounts in all pain syndromes and are responsible for the pain experience. Classification and treatment of pain syndromes should depend on the complex inflammatory profile. A variety of mediators are generated by tissue injury and inflammation. These include substances produced by damaged tissue, substances of vascular origin as well as substances released by nerve fibers themselves, sympathetic fibers and various immune cells. Biochemical mediators of inflammation that are targeted for inhibition include but are not limited to: prostaglandin, nitric oxide, tumor necrosis factor alpha, interleukin 1-alpha, interleukin 1-beta, interleukin-4, Interleukin-6 and interleukin-8, histamine and serotonin, substance P, Matrix Metallo-Proteinase, calcitonin gene-related peptide, vasoactive intestinal peptide as well as the potent inflammatory mediator peptide proteins neurokinin A, bradykinin, kallidin and T-kinin.

An aluminum oxde-coated article has a first coating layer and a second coating layer formed in this order on a substrate, the first coating layer having a single- or multi-layer structure and being made of at least one selected from the group consisting of carbides, nitrides, carbonitrides, oxides, oxycarbides, oxynitrides and oxycarbonitrides of metals in Groups IVa, Va and VIa of the Periodic Table, and the second coating layer being constituted by at least one alpha-aluminum oxide-based oxide layer, which has an equivalent X-ray diffraction peak ratio PR (1 0 10) of 1.3 or more in a (1 0 10) plane.